Skip to content
China-U.S. biotech ventures are where collaboration meets competition
“I think we’re in a very exciting time in healthcare and biotech,” said ...
Read More
BIO submits comments on framework for biotech regulation
On Friday, the Biotechnology Innovation Organization (BIO) submitted biotech regulation comments on the Administration’s ...
Read More
Are SPACs dead? – and other questions about the biotech market outlook
The narrative is that it’s a bad market for biotech, but CEOs and ...
Read More
5 things to know about clinical trials
On Day 1 of the BIO CEO and Investor Conference, a panel—Prioritizing CRO ...
Read More
What BIO’s watching on health care and agriculture policy in 2023
With the 118th Congress picking up steam, the Biotechnology Innovation Organization’s (BIO) Federal ...
Read More
Pfizer Ignite’s new model is turning heads and sharing the wealth
“It’s exciting times,” said Kathy Fernando, Senior Vice President and Global Head of ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
Health
BIO-CSBA report explains why and how states seek to attract biotech
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are implementing policies designed to attract ...
Federal Policy
Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation
When it comes to enabling new treatments for type 1 diabetes (T1D), Breakthrough T1D is an outstanding example of a patient group driving research and ...
BIO Events
BIO 2025 IP Conference: Challenging times for the laws that drive innovation
Patents offer the intellectual property protections investors need to support biotech innovation. That’s why the Biotechnology Innovation Organization (BIO) annual IP Council and Committees (IPC) ...
Latest News
National Family Caregivers Month: Recognizing 63 million Americans
November is National Family Caregivers Month, and to mark the occasion, Bio.News sat down with the National Alliance for Caregiving (NAC) to discuss the crucial ...
BIO's View
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely access to essential medicines, a ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO-CSBA report explains why and how states seek to attract biotech
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are ...
Read More
International
Bio's View
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely ...
Read More
